Contact Us | News |  Site Map

Aridis Pharmaceuticals  © 2010   Le3 Web Designs

Privacy Policy

Convenient, Effective Therapies

for Infectious Diseases

June 29th, 2010. Aridis receives notice of award from the US Department of Defense totaling $2.4m to develop gallium based antimicrobial for topical treatment of wound infection pathogens.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
July 23rd, 2010. Aridis receives notice of award from the US Dept. of Health & Human Services totaling $3m to develop stable formulation for influenza vaccines.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

January 8th, 2010  Aridis out-licenses formulation stabilization technologies to a major vaccine and biologics company.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

September 30th, 2009  Aridis awarded a National Institute of Health grant award to develop advanced formulation for third generation anthrax vaccines.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

June 17th, 2009  Aridis awarded SBIR Award from the National Institute of Allergy and Infectious Diseases, NIH to develop inhalable gallium based therapeutics.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

January 29th, 2009Aridis awarded U.S. Agency for International Development (USAID) award in collaboration with Mapp BioPharmaceutical to develop microbicides monoclonal antibodies.

>> More news